Tyr-Somatostatin-14,58100-03-1, Peptide synthesis

Dirction：Tyr-Somatostatin-14 (GT-P1731, CAS 58100-03-1) is a synthetic peptide with a disulfide bridge between Cys4 and Cys15. Its formula is C₈₅H₁₁₃N₁₉O₂₁S₂ and MW 1801.09. Manufactured via solid-phase peptide synthesis, it is supplied for endocrine and somatostatin receptor related academic research with reliable purity.

oinarrizko informazioa:

marka: luzapen sendoa

itxura ezaugarriak:zuriahautsa

biltegiratze: itzaldura, freskoalehortzea,zigilatutako kontserbazio garbitasuna: ≥% 99 erabilera nagusia: Polipeptidoen Ikerketa Erabilera

exekuzioaestandar: enpresa estandarra

zehaztapenak:mg/g/kg, etab (bezeroen eskakizunen arabera)

salmenta Eremua: Globala

peptidoen maiz egiten diren galderak:

1. How to judge whether the quality of peptide synthesis is qualified?

Each polypeptide will come: -HPLC chromatogram (purity test) -MS (Molecular Weight Verification) after the customer receives it, it can be verified again in combination with the experimental requirements, and can be retested and confirmed if necessary.

2. What modifications are supported? Does the modification affect the cycle?

Supporting modifications include, but are not limited: -Fluorescent labeling (FITC, Cy5, etc.) -Cyclization, phosphorylation, fatty acid -Biotinylation, C- terminal amidation, N-terminal acetylation, etc. Complex modification will appropriately extend the synthesis cycle, generally 7 to 12 working days, it is recommended to evaluate in advance.